www.fdanews.com/articles/198340-wockhardt-to-provide-covid-19-vaccine-manufacturing-to-the-uk
Wockhardt to Provide COVID-19 Vaccine Manufacturing to the UK
August 4, 2020
India-based drugmaker Wockhardt will provide fill-and-finish services for millions of doses of a COVID-19 vaccine under a new contract with the UK government.
In the 18-month deal, the UK government has reserved exclusive manufacturing capacity from Wockhardt subsidiary CP Pharmaceuticals for fill-and-finish production of multiple vaccines, including AstraZeneca’s and Oxford University’s promising vaccine candidate AZD1222.
The company will begin production next month at its facility in North Wales.